Tricida Inc (TCDA) Return on Equity ROE from the third quarter 2022 to third quarter 2021 and annually, average high and low, overall ranking from Sep 30 2022 to Sep 30 2021 - CSIMarket
CSIMarket Company Name, Ticker, Customers, else..
 


• ROA Quarterly
• ROI Quarterly
• ROE Quarterly
Tricida Inc   (NASDAQ: TCDA)

Tricida Inc 's ROE per quarter

Return on Equity, Quarterly Results, Trends, Rankings, Statistics


What is ROE for Tricida Inc in the third quarter 2022?
Due to the lack of equity, it was not possible to calculate Tricida Inc 's return on equity (ROE) in its third quarter 2022

What is ROE?



Download as CSV
Commercial Data Licensing & OEM
Annual commercial subscriptions for corporate use, internal BI systems, management reporting, AI integration, and client-facing platforms
API & Data Feeds
Programmatic access to normalized fundamentals & ratios.

Return On Equity (Sep 30 2022)
III. Quarter		 (Jun 30 2022)
II. Quarter		 (Mar 31 2022)
I. Quarter		 (Dec 31 2021)
IV. Quarter		 (Sep 30 2021)
III. Quarter
Y / Y Equity Change - - - -99.8 % -
Y / Y Net Income Change - - - - -
Net Income (TTM) in Millions -61 -114 -153 -177 -655
Return On Equity (TTM) - - - -716.22 % -1264.74 %
TCDA's Total Ranking # # # # #
Equity (TTM) in Millions -136 -111 -90 0 2
Seq. Equity Change - - - -88.54 % -94.55 %
Seq. Net Income Change - - - - -

Back to TCDA Management Effectiveness >> TCDA's 5 Years Annual ROE >> Compare TCDA ROE to its Competitors
Return On Equity Company Ranking
Within: No.
Industry #
Sector #
Overall #

Return On Equity Statistics
High Average Low
0 %
0 %
0 %
 





TCDA Annual Return On Equity (Dec 31 2021)
2021		 (Dec 31 2020)
2020		 (Dec 31 2019)
2019		 (Dec 31 2018)
2018
Total Equity in Millions 0 109 264 195 0
Y / Y Equity Change -99.8 % -58.74 % 35.66 % - -
Net Income in Millions -177 -530 0 -103 0
Y / Y Net Income Change - - - - -
Return On Equity -80993.58 % -486.43 % 0.03 % -52.85 % -

Back to TCDA Management Effectiveness >> TCDA's 5 Years Annual ROE >> Compare TCDA ROE to its Competitors




More Return On Equity Ratios
Major Pharmaceutical Preparations Industry Roe Trends and Statistics
Healthcare Sector Return On Equity Statistics
TCDA's' Return on Equity at Yahoo Finance
TCDA's Roe Ratio versus Major Pharmaceutical Preparations Industry, Healthcare Sector and overall Market
Highest Ranking Return On Equity
Lowest Ranking Return On Equity
Subscribers only: Roe for TCDA's Competitors
Subscribers only: Roe for Tricida Inc 's Suppliers
Subscribers only: Return On Equity for TCDA's Customers




Companies with similar Return On Equity at Sep 30 2022, within Healthcare Sector ROE
Waters Corporation  194.97 %
Chimerix Inc   147.04 %
Idexx Laboratories Inc  118.38 %
Biofrontera Inc   105.90 %
Davita Inc   105.42 %
Halozyme Therapeutics Inc   99.70 %
Dynavax Technologies Corporation  90.76 %
Biomx Inc  89.58 %
Vivos Therapeutics Inc   86.64 %
Abbvie Inc   85.92 %
Puma Biotechnology Inc   83.55 %
Avid Bioservices Inc   80.43 %
Maravai Lifesciences Holdings Inc   75.23 %
Aptevo Therapeutics Inc   74.95 %
Ir med Inc   71.86 %
Moderna Inc   70.03 %
Sensus Healthcare Inc   66.57 %
Cartesian Therapeutics Inc   66.02 %
Siga Technologies Inc  65.91 %
Eli Lilly And Company  64.45 %
Journey Medical Corp  64.37 %
Kiniksa Pharmaceuticals International Plc  64.16 %
Harmony Biosciences Holdings inc   62.81 %
Vir Biotechnology Inc   60.66 %
Innoviva Inc   58.51 %
Glucotrack Inc   57.65 %
Tenet Healthcare Corp  52.50 %
Vicarious Surgical Inc  51.97 %
Oncotelic Therapeutics Inc   51.28 %
Cryo cell International Inc   49.59 %

Date modified: 2026-09-08T15:10:46+00:00



Help

About us

Products

Data downloads

API

CSIMarket Company, Sector, Industry, Market Analysis, Stock Quotes, Earnings, Economy, News and Research.

Intraday data delayed per exchange requirements. All quotes are in local exchange time. Intraday data delayed 15 minutes for Nasdaq, and other exchanges. Fundamental and financial data for Stocks, Sector, Industry, and Economic Indicators provided by CSIMarket.com

Disclaimer: Information provided by CSIMarket.com is for informational purposes only and does not constitute investment advice, recommendation, or solicitation to buy or sell any security.

© 2026 CSIMarket.com — Proprietary financial dataset. All rights reserved. Redistribution or automated extraction prohibited.